Page last updated: 2024-10-25

clonazepam and Hyperkinetic Dysphonia

clonazepam has been researched along with Hyperkinetic Dysphonia in 2 studies

Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, RA1
Hallahan, B1
Hattori, H1
Yoshikawa, F1
Sato, H1
Fujimine, T1

Other Studies

2 other studies available for clonazepam and Hyperkinetic Dysphonia

ArticleYear
Psychosis improved dysphonia.
    BMJ case reports, 2013, Dec-09, Volume: 2013

    Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Clonazepam; Diagnosis, Differential

2013
Spasmodic dysphonia in Meige syndrome responding to clonazepam.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18

    Topics: Clonazepam; Dysphonia; Electromyography; GABA Modulators; Humans; Male; Meige Syndrome; Middle Aged;

2011